Medicare patients who accessed opioid use disorder treatment through telehealth services during the pandemic were more likely to stay in treatment and less likely to experience an overdose than patients without telehealth access to OUD treatment, according to a federal study published last week in JAMA Psychiatry.

“Telehealth is a valuable service and when coupled with medications for opioid use disorder can be lifesaving,” said Wilson Compton, M.D., deputy director of the National Institute on Drug Abuse and senior author of the study. “This study adds to the evidence showing that expanded access to these services could have a longer-term positive impact if continued.”

Headline
The Medicare Payment Advisory Commission March 12 released its March 2026 report to Congress, which includes its recommended payment rates for hospital…
Headline
The Centers for Medicare & Medicaid Services March 11 issued guidance to state survey agency directors clarifying and reinforcing the roles and…
Headline
The Joint Economic Committee March 10 released a report that found Medicare Part B premiums rose last year due to Medicare Advantage overpayments. The…
Headline
The Substance Abuse and Mental Health Services Administration announced March 6 that it will award $69.1 million in grants for mental health and suicide…
Headline
The Centers for Medicare & Medicaid Services Feb. 25 released a request for information on potential regulatory changes in a possible future…
Headline
The Centers for Medicare & Medicaid Services Feb. 23 announced the development of its Medicare App Library. As part of the agency’s Health Technology…